Arsenic Trioxide With or Without Ascorbic Acid in Treating Patients With Myelofibrosis

Clinical trial NCT01014546 · TERMINATED

Trial details

NCT number: NCT01014546
Sponsor: Roswell Park Cancer Institute
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Essential Thrombocythemia Polycythemia Vera Primary Myelofibrosis

Start date: 2010-04-01
Primary completion: 2015-02-01
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.